155 Results for “William Lazonick”

What we’re reading: A weekly scan of published items relevant to the Institute’s work

New book reveals how and why hedge-fund activists have been able to suck the life from big-name companies like J.C. Penney and Samsung with their short-sighted profit-grabs. Can their harmful activities be stopped?

How the dream of a middle class existence collapsed, first for Blacks, then for more and more white American workers and what the Biden administration could do to retrieve the situation.

Current proposals will worsen inequality and harm those Trump promised to protect—while further enriching the top 1%

Much historical commentary emphasizes how pandemics restructure long-standing social and political arrangements. The observation applies to macroeconomics as well.

What is GM CEO Mary Barra’s take-home pay? (It’s more than you are being told)

Instead of rewarding the taxpayers and employees who actually create value for the tech giant, Apple is doling out massive stock buybacks

Public funding behind the technology is the secret ingredient.

Cisco’s turn from innovation to financialization and what it means for the competitive position of the US information-and-communication-technology industry

Reindustrialization vs Financialization

President Biden’s first SOTU Address was a missed opportunity to say what he knows to be true: Stock buybacks manipulate the market and leave most Americans worse off

Stock buybacks as a mode of predatory value extraction

History shows robust antitrust enforcement helps promote a prosperous, fair, and balanced economy. Antitrust expert Mark Glick explains how the U.S. went astray during the 1980s, and how to get back on track.

Post-Chicago Economists vs. New Brandeisians on the New Merger Guidelines

Dr. Victor Gurewich, a researcher and Harvard Medical School faculty member since 1965, discovered a breakthrough drug treatment for heart attacks and strokes with the potential to save millions, but institutional resistance and a U.S. healthcare system that puts profits over patients are keeping it out of reach.